HealthCorticosteroid Emflaza Receives FDA Approval As Duchenne Muscular Dystrophy Treatment A new drug approved by the FDA has been shown to delay loss of walking ability for patients diagnosed with Duchenne muscular dystrophy. Emflaza is marketed by Marathon Pharmaceuticals.by Dianne Depra
HealthKaleo Pharmaceuticals Questioned Over 550 Percent Price Hike Of Naloxone Injector Evzio For Opioid Overdoseby Allan Adamson
HealthFalse Alarm Mammograms Can Cause Women To Skip Or Delay Future Breast Cancer Screeningby Allan Adamson
HealthMillions Of Americans Likely Have Hearing Loss Without Knowing It: What Can Be Done?by Katrina Pascual
HealthMake Or Break: How Will Childhood Cancer Treatments Affect Future Sex Lives Of Young Patients?by Arrianne Del Rosario
10 Hidden Android Tricks and Settings Tips in Android 2025 That Instantly Boost Your Phone Experience
First Look at Nintendo's Live-Action 'The Legend of Zelda' Movie Starring Bo Bragason and Benjamin Evan Ainsworth